LUNG SQUAMOUS CELL CARCINOMA
Clinical trials for LUNG SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LUNG SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for LUNG SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New injection JMT106 enters first human tests for advanced cancers
Disease control Recruiting nowThis early-phase study tests a new drug called JMT106 in 200 adults with advanced solid tumors (including lung and liver cancer) who have tried other treatments without success. The main goals are to check safety, find the best dose, and see if the drug can shrink tumors. Partici…
Matched conditions: LUNG SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: Shanghai JMT-Bio Inc. • Aim: Disease control
Last updated Apr 30, 2026 15:52 UTC
-
New targeted therapy TER-2013 enters trials for Hard-to-Treat cancers
Disease control Recruiting nowThis study tests an experimental drug called TER-2013 in people with advanced solid tumors (like breast, endometrial, ovarian, lung, head and neck, esophageal, or cervical cancer) that have specific genetic changes in the AKT/PI3K/PTEN pathway. The trial has two phases: first, fi…
Matched conditions: LUNG SQUAMOUS CELL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Terremoto Biosciences Inc. • Aim: Disease control
Last updated Apr 28, 2026 13:02 UTC